[Class : 5] Pharmaceutical Products And Its Preparations.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical Products And Its Preparations.
Renewal of trademark is overdue. Renewal with Restoration request in prescribed form is to be filed by the applicant.
View +1 more Brands for Medimerz Pharma Private Limited.
Documents
Form MGT-7-14122019_signed
Form AOC-4-14122019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29112019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-29112019
Directors report as per section 134(3)-29112019
Optional Attachment-(1)-29112019
List of share holders, debenture holders;-29112019
Form ADT-1-23102019_signed
Copy of resolution passed by the company-14102019
Copy of written consent given by auditor-14102019
Copy of the intimation sent by company-14102019
Form DPT-3-07082019-signed
Auditor?s certificate-25062019
Form DIR-12-01062019_signed
Evidence of cessation;-01062019
Form DIR-12-15122018_signed
Optional Attachment-(1)-14122018
Evidence of cessation;-14122018
Optional Attachment-(1)-22112018
List of share holders, debenture holders;-22112018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-22112018
Directors report as per section 134(3)-22112018
Form MGT-7-22112018_signed
Form AOC-4-22112018_signed
Form AOC-4-01122017_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-27112017
Directors report as per section 134(3)-27112017
Optional Attachment-(1)-27112017
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-27112017